pharma news today glp-1 obesity drugs today Agonists Weight Loss Market Report, 2025-2030 Drugmaker Eli Lilly announced that

Oral semaglutide 50 mg In people with obesity without T2D, a 68-week phase 3 trial (OASIS-1) assessed the safety and efficacy of oral semaglutide 50 mg once daily vs

Genetic clues: Are there any diets that can address the biology that underlies autism

A preformulation drug characterization of niclosamide (pKa, water-solubility, and LogP) was carried out along with an experimental evaluation of the amount of niclosamide that could be dissolved in aqueous solution as a function of pH

Enhanced bioavailability of anemoside B4 by dry powder inhalation mitigates high-altitude acute lung injury

Fatigue management If early dosing leaves you feeling more tired than usual, focus on protein intake and hydration

V vy, trc khi s dng bn nn tham kho kin bc s m bo sn phm hoc liu trnh b sung ph hp v mang li hiu qu tt nht cho ln da cng nh sc khe ca mnh